OBJECTIVE: MFG-E8 (also called lactadherin and SED1) is a secreted glycoprotein that has been previously implicated in enhancement of vascular endothelial growth factor-dependent angiogenesis. Major sources of MFG-E8 in vivo and precise mechanisms of MFG-E8 action remain undetermined. The objective of this study was to identify important sources of MFG-E8 in vivo and further elucidate the role(s) of MFG-E8 in the regulation of angiogenesis. METHODS AND RESULTS: We used knockout mice and anti-MFG-E8 antibodies to study MFG-E8 function in vivo. In melanomas and in retinas of mice with oxygen-induced retinopathy, MFG-E8 colocalized with pericytes rather than endothelial cells, and platelet-derived growth factor receptor β+ pericytes/pericyte precursors purified from tumors contained large amounts of MFG-E8 mRNA. Tumor- and retinopathy-associated angiogenesis was diminished in MFG-E8 knockout mice, and pericyte coverage of neovessels was reduced. Inhibition of MFG-E8 production by 10T1/2 cells (surrogate pericyte/pericyte precursors) using small interfering RNAs and short hairpin RNAs, or inhibition of MFG-E8 action with some anti-MFG-E8 antibodies, selectively attenuated migration in vitro. Significantly, the anti-MFG-E8 antibodies that inhibited 10T1/2 cell migration in vitro also inhibited pathological angiogenesis in vivo. CONCLUSIONS: These studies strongly implicate MFG-E8 in pericyte/pericyte precursor function and indicate that MFG-E8-directed therapeutics may merit further development.
OBJECTIVE:MFG-E8 (also called lactadherin and SED1) is a secreted glycoprotein that has been previously implicated in enhancement of vascular endothelial growth factor-dependent angiogenesis. Major sources of MFG-E8 in vivo and precise mechanisms of MFG-E8 action remain undetermined. The objective of this study was to identify important sources of MFG-E8 in vivo and further elucidate the role(s) of MFG-E8 in the regulation of angiogenesis. METHODS AND RESULTS: We used knockout mice and anti-MFG-E8 antibodies to study MFG-E8 function in vivo. In melanomas and in retinas of mice with oxygen-induced retinopathy, MFG-E8 colocalized with pericytes rather than endothelial cells, and platelet-derived growth factor receptor β+ pericytes/pericyte precursors purified from tumors contained large amounts of MFG-E8 mRNA. Tumor- and retinopathy-associated angiogenesis was diminished in MFG-E8 knockout mice, and pericyte coverage of neovessels was reduced. Inhibition of MFG-E8 production by 10T1/2 cells (surrogate pericyte/pericyte precursors) using small interfering RNAs and short hairpin RNAs, or inhibition of MFG-E8 action with some anti-MFG-E8 antibodies, selectively attenuated migration in vitro. Significantly, the anti-MFG-E8 antibodies that inhibited 10T1/2 cell migration in vitro also inhibited pathological angiogenesis in vivo. CONCLUSIONS: These studies strongly implicate MFG-E8 in pericyte/pericyte precursor function and indicate that MFG-E8-directed therapeutics may merit further development.
Authors: Kamran Atabai; Sina Jame; Nabil Azhar; Alex Kuo; Michael Lam; William McKleroy; Greg Dehart; Salman Rahman; Dee Dee Xia; Andrew C Melton; Paul Wolters; Claire L Emson; Scott M Turner; Zena Werb; Dean Sheppard Journal: J Clin Invest Date: 2009-11-02 Impact factor: 14.808
Authors: Kip M Connor; Nathan M Krah; Roberta J Dennison; Christopher M Aderman; Jing Chen; Karen I Guerin; Przemyslaw Sapieha; Andreas Stahl; Keirnan L Willett; Lois E H Smith Journal: Nat Protoc Date: 2009-10-08 Impact factor: 13.491
Authors: Mingyi Wang; Zongming Fu; James Wu; Jing Zhang; Liqun Jiang; Benjamin Khazan; Richard Telljohann; Mingming Zhao; Alexander W Krug; Maria Pikilidou; Robert E Monticone; Robert Wersto; Jennifer Van Eyk; Edward G Lakatta Journal: Aging Cell Date: 2012-04-04 Impact factor: 9.304
Authors: Ke Yuan; Elya A Shamskhou; Mark E Orcholski; Abinaya Nathan; Sushma Reddy; Hiroaki Honda; Vigneshwaran Mani; Yitian Zeng; Mehmet O Ozen; Lingli Wang; Utkan Demirci; Wen Tian; Mark R Nicolls; Vinicio A de Jesus Perez Journal: Circulation Date: 2019-04-02 Impact factor: 29.690
Authors: Amitava Das; Subhadip Ghatak; Mithun Sinha; Scott Chaffee; Noha S Ahmed; Narasimham L Parinandi; Eric S Wohleb; John F Sheridan; Chandan K Sen; Sashwati Roy Journal: J Immunol Date: 2016-05-18 Impact factor: 5.422